PFA: A New Frontier in Atrial Fibrillation Treatment copertina

PFA: A New Frontier in Atrial Fibrillation Treatment

PFA: A New Frontier in Atrial Fibrillation Treatment

Ascolta gratuitamente

Vedi i dettagli del titolo

A proposito di questo titolo

Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting over 1.4 million people in the UK alone. We speak with Dr Angelo Auricchio of Boston Scientific about an innovative technology—now recommended by NICE—that could help reduce waiting lists while also addressing the associated risks of stroke and heart failure.

Hosted on Acast. See acast.com/privacy for more information.

Ancora nessuna recensione